Authors found low adherence to CDC recommendations for boosters, with older adults more likely to receive at least four mRNA COVID-19 vaccine doses.
Furthermore, intimate partner violence tied to lower likelihood of achieving viral suppression among HIV-positive women.
Researchers evaluated whether HIV DNA persists in the liver among individuals receiving suppressive antiretroviral therapy.
Mosaico trial investigator Dr Stephaun Wallace explains why developing an effective HIV vaccine remains challenging.
A woman in her mid-20s presents to the emergency department with a 2-day history of sore throat and fever (102.9 ⁰F). Can you make the diagnosis?
The tools used in an adolescent transition program to aide patients with HIV infection transition to independent care were evaluated for effectiveness.
The preliminary safety signal was identified by the CDC’s Vaccine Safety Datalink.
Researchers sought to evaluate differences in immunologic markers between those with HIV and those at risk for HIV with opioid use disorder.
Recent COVID-19 updates include a successful pacing program for people with long COVID symptoms, a blood marker for post-vaccine myocarditis, and the first home test-to-treat program.
Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff in nursing homes.
Based on existing literature, the potential mechanism, clinical characteristics, and treatment of COVID-19-associated arthritis is discussed.
Researchers sought to assess whether individuals with hypertension have a higher risk for severe COVID-19 compared with those without hypertension and whether systolic blood pressure or the type of antihypertensive medication affects that risk.
Researchers evaluated rates of infection-related and infection-unrelated cancers among younger and older adults with HIV infection.
No evidence that large numbers of nurses left health care or hospital practice during first 18 months of pandemic.
The issue appears to be related to the availability of generic oseltamivir.
The percentage of COVID-19 deaths with long COVID peaked in June 2021 and April 2022 at 1.2% and 3.8%
SGLT2 inhibitors are associated with lowest probability for adverse outcomes followed by GPL1 receptor agonists and metformin
Because people with HIV are living longer, management of comorbidities throughout the life span is increasingly important.
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, the tripledemic of RSV, COVID-19, and influenza continues throughout the holiday season.